Home » Topics » Regulatory

Regulatory
RSS

MSD obtains approval for Renivace in new indication

June 22, 2012

FDA approves MenHibrix

June 15, 2012

FDA approves Roche antibody for use in combination cancer therapy

June 11, 2012

FDA approves Horizant for new indication

June 8, 2012

AstraZeneca obtains approval for Inderal for new indication in Japan

May 25, 2012

Ocera obtains CE Mark for Zysa

May 21, 2012

First drug approved in E.U. for multiply relapsed/refractory aggressive NHL

May 11, 2012

FDA approves expanded dose range for schizophrenia drug

May 7, 2012

FDA approves Levaquin for new indication

May 4, 2012

FDA approves new therapy for type 1 Gaucher's disease

May 2, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 12, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
CTAD 2025: The challenges of combination therapies for dementia
BioWorld Science
At the Clinical Trials on Alzheimer’s Disease 2025 meeting, a panel of experts discussed the need for developing combination therapies for the complex diseases...
DEE-lightful: Praxis’ phase II results allow stock to flex its muscle
BioWorld
Positive efficacy results led to Praxis Precision Medicines Inc.’s phase II Embold study in developmental and epileptic encephalopathies (DEEs) being halted...